Interleukin-1 induces blood-brain barrier disruption by downregulating sonic hedgehog in astrocytes
Each peptide has been examined separately in preclinical and cell-based laboratory research: BPC-157 in peptide signalling studies, TB-500 (a thymosin beta-4 fragment) in actin-binding and cytoskeletal research, and GHK-Cu in copper-dependent biochemical and regulatory pathway research
Yes, most lab work is completed directly at our Egg Harbor Township clinic, allowing for faster results and a more streamlined experience
How do Lipo-B (MIC) Injections work, and are the effects permanent
GHK-Cu affects over 4,000 human genes, upregulating pathways associated with tissue maintenance and downregulating inflammatory and degenerative cascades
For a full breakdown of how BPC-157 fits into the Wolverine Stack and what patients can expect from the combination, see our complete Wolverine Stack guide